The otolaryngologist has been named a Center of Excellence provider in New Jersey, recognizing his expertise in a non-invasive treatment that improves nasal breathing for patients with chronic congestion.
For drug-induced sleep endoscopy to determine sleep apnea therapy candidacy, the first 10+ minutes may not be representative of airway collapse.
Patients experienced significant nasal obstruction symptom improvements at three months following treatment.
Following a single treatment with RhinAer, symptom severity significantly decreased in the first two weeks and remained low through the one-year follow-up.
Read MoreThe newly published study found that 97.2% of patients had a significant and sustained reduction in their nasal obstruction symptoms through two years, without any significant device-related adverse events.
Read More
A surgeon explains how procedures such as in-office balloon sinuplasty may subjectively improve...
Read More
Researchers at The Ohio State University Wexner Medical Center are exploring how small changes in the nasal cavity impact airflow and quality of life.
Read MoreOfficially called the da Vinci Surgical System, doctors control the robot’s tiny instruments from a console a couple feet away, reports DelawareOnline. Now ear, nose and throat surgeons have started using the robot to...
Read More
Obstructive sleep apnea is a heterogeneous disease in which patients differ in their severity, physical features, and treatment preferences. For almost two decades, otolaryngologist and sleep medicine specialist Ofer Jacobowitz, MD, PhD, FAASM, of ENT and Allergy Associates LLP in New York City, has been matching CPAP, custom oral appliances, sleep surgery, and combination treatments to his patients.
Read MoreBoxBar Vascular, under the leadership of board certified surgeon Ellen Derrick, MD MPH FACS, opened its doors in Seattle this month with a mission to improve not only the vascular health and well-being of patients but their...
Read More
CPAP is the gold standard for obstructive sleep apnea, but what about patients who can’t—or won’t—tolerate it or who need an additional therapy? We profile the spectrum of FDA-approved therapies, including when to try them, considerations for each, and new developments.
Read MoreCraig Schwimmer, MD, MPH, FACS, founder and CEO of Snoring Center USA LLC, announced the formation of Pillar Palatal LLC, and its acquisition of the Pillar Procedure business from Medtronic Inc, effective January 17, 2014. The...
Read MoreHealth Canada has approved sale of St Paul, Minn-based, Restore Medical’s Pillar® Palatal Implant System, providing Canadians access to the FDA-cleared palatal implant to treat snoring and mild-to-moderate obstructive sleep apnea (OSA).
Read More